Commissioning Policy (EMSCGP006V2) For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services
Although Primary Care Trusts (PCTs) and East Midlands Specialised Commissioning Group (EMSCG) were abolished at the end of March 2013 with the formation of 5 Nottinghamshire County wide clinical Commissioning Groups (CCGs) policies that were in place prior to 1 April 2013 remain in place to ensure a consistent approach. The NHS Nottingham North & East Clinical Commissioning Group have adopted this policy, in its existing form, at a meeting of its Governing Body on 20 August 2013. This policy sets the overall parameters within which care will be delivered.
East Midlands Specialised Commissioning Group
Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services Reference No:
EMSCGP006V2
Version:
2
Ratified by:
EMSCG
Date ratified:
25 March 2011
Name of originator/author:
David Giffard
Name of responsible committee/individual:
EMSCG Clinical Priorities Group
Date issued:
1 April 2011
Review date:
31 March 2012
Target audience:
PCT Commissioners, Providers of Service
Distributed via:
Postmaster Email Website: www.emscg.nhs.uk
Commissioning Policy for Tertiary Infertility Services incorporating IVF/ICSI Version 2 POLICY NO: 006
Page 1 of 1
East Midlands Specialised Commissioning Group
East Midlands Specialised Commissioning Group Commissioning Policy for Tertiary Infertility Services incorporating IVF/ICSI Version Control Sheet Draft
Section/Para/ Appendix
1 2
Criteria
3
Contents
Treatment
Resources Implications Review
Version/Description of Amendments
Date
Author/Amended by
1st Draft
9.2.10
DG
Woman’s age amended to reflect current position The statement ‘Patients who have been referred by their GP for infertility treatment on or after 1 December 2010 will be treated in accordance with this policy. Those referred prior to this date will be treated in accordance with the EMSCG Commissioning Policy for IVF/ICSI within tertiary Infertility Services policy issued on 1 August 2008’ has been removed
25.11.10
DG
29.03.11
DG
Within the definition of a completed IVF/ICSI cycle the term viable pregnancy has been replaced with live birth The statement ‘Viable Pregnancy = To be established by an ultrasound scan before the end of the 8th week of pregnancy’ has been removed Table amended to reflect drug & treatment costs combined Review date changed to reflect amendments to policy
Commissioning Policy for Tertiary Infertility Services incorporating IVF/ICSI Version 2 POLICY NO: 006
Page 2 of 2
East Midlands Specialised Commissioning Group
East Midlands Specialised Commissioning Group Commissioning Policy for Tertiary Infertility Services incorporating IVF/ICSI Contents i.
Version control sheet
Section
Page
1
Policy
4
2
Criteria
4
3
Treatment
5
4
Epidemiology
6
5
Resource Implications
7
6
Evidence Base (and Health Benefits)
7
7
Mechanism for Funding
7
8
Review Date
7
9
Glossary
8
10
References
9
Commissioning Policy for Tertiary Infertility Services incorporating IVF/ICSI Version 2 POLICY NO: 006
Page 3 of 3
East Midlands Specialised Commissioning Group
1
Policy IVF can be a legitimate medical intervention as part of NHS provision where a couple have a medical reason for being unable to conceive a child. The SCG accepts that it may not always be possible to identify the precise nature of the medical reason and thus infertility is defined as failure to conceive after frequent unprotected sexual intercourse for one to two years in couples in the reproductive age group or by undertaking 6 cycles of Donor Insemination without conceiving or by having a defined tubal blockage thereby preventing conception. Couples who are able to demonstrate this and fulfil the following criteria will be eligible for tertiary infertility treatments under this agreement. All other treatments that may be required before couples are referred for IVF/ICSI treatment are PCT commissioned and are not covered by this policy. These include Donor Insemination, Intra Uterine Insemination & Ovulation Induction. Patients should be referred and treated in accordance with the 18 week pathway rules.
2
Criteria Woman’s Age
23 – 39 years (Stimulation treatment must take place before the patients 40th birthday)